The drug regulatory body of India will consider emergency use approval for Zydus Cadila’s Covid-19 vaccine this week and the…
The All India Medical Institute of Medical Sciences (AIIMS) is expected to start screening of children for clinical trials of…
New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has…
The Drugs Controller General of India (DCGI) has permitted Bharat Biotech to give a third dose of Covaxin to a…